Brief: Evelo Biosciences Presents Data On EDP1815 Mechanism Of Action And Supporting Ongoing Clinical Development For Inflammatory Diseases
17/01/2022 12:09
Jan 17 (Reuters) - Evelo Biosciences Inc EVLO.O :
* EVELO BIOSCIENCES PRESENTS DATA ON EDP1815 MECHANISM OF
ACTION
AND SUPPORTING ONGOING CLINICAL DEVELOPMENT FOR INFLAMMATORY
DISEASES
Source text for Eikon: ID:nGNX8pfmCX
Further company coverage: EVLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evelo Biosciences
See all newsU.S. RESEARCH ROUNDUP- Evelo Biosciences, Nkarta, O'Reilly Automotive
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Evelo Bio slumps after skin disease drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI